title: Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.
authors.affiliation: Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: José
authors.initials: J
authors.lastname: Rubio-Briones
authors.forename: Antonio
authors.initials: A
authors.lastname: Fernández-Serra
authors.forename: Ana
authors.initials: A
authors.lastname: Calatrava
authors.forename: Zaida
authors.initials: Z
authors.lastname: García-Casado
authors.forename: Luis
authors.initials: L
authors.lastname: Rubio
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Bonillo
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Iborra
authors.forename: Eduardo
authors.initials: E
authors.lastname: Solsona
authors.forename: José A
authors.initials: JA
authors.lastname: López-Guerrero
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018450:Disease Progression; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D050939:Gene Fusion; D006801:Humans; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011379:Prognosis; D016016:Proportional Hazards Models; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000601:surgery*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D015514:Oncogene Proteins, Fusion; C515553:TMPRSS2-ERG fusion protein, human